The average number of drugs per prescription was 7.42. Prescriptions of at least one injectable drug or antibiotic were found in 58,00 % and 80,20 % of prescriptions, respectively. Half of prescribed drugs were part of the National List of Essential Drugs (50,33 %) and the Municipal List of Essential Drugs (55,24 %), both version 2006. The prevailing therapeutic classes were the analgesics (8.09 %) and anti-emetics (4.61 %). Incomplete medical prescriptions difficult drug use and hinder the service efficiency, putting at risk the quality of user assistance.”
“Objective: To estimate the associations between maternal vitamin D status and adverse pregnancy outcomes.
Study
design: We searched electronic databases of the human literature in PubMed, EMBASE and the Cochrane AZD6094 mouse Library up to October, Pexidartinib nmr 2012 using the following keywords: “”vitamin D”" and “”status”" or “”deficiency”" or “”insufficiency”"
and “”pregnancy”". A systematic review and meta-analysis were conducted on observational studies that reported the association between maternal blood vitamin D levels and adverse pregnancy outcomes including preeclampsia, gestational diabetes mellitus (GDM), preterm birth or small-for-gestational age (SGA).
Results: Twenty-four studies met the inclusion criteria. Women with circulating 25-hydroxyvitamin D [25(OH)D] level less than 50 nmol/l in pregnancy experienced an increased risk of preeclampsia [odds ratio (OR) 2.09 (95% confidence intervals 1.50-2.90)], GDM [OR 1.38 (1.12-1.70)], preterm birth [OR 1.58 (1.08-2.31)] and SGA [OR 1.52 (1.08-2.15)].
Conclusion: Low maternal vitamin D levels in pregnancy may be associated with an increased risk of preeclampsia,
GDM, preterm birth and SGA.”
“The aim of this study was to evaluate pharmaceutical counseling following hospital discharge. All subjects received pharmacist counseling before discharge in a private hospital in Aracaju-SE, Brazil, from October 2007 to February 2008. Medication adherence was measured by Haynes-Sacket and Morisky-Green-Levine scales at the end of post-discharge treatment. Post-surgery patients (n = 243) received counseling PXD101 cost on the day of hospital discharge, while adherence was observed in 186 (76.5 %) of these patients. During the four months, the increase in adherence was observed in those patients that received the counseling: 68.7%, 73.6 %,82.9 % and 85.7 %, respectively. The patients were distributed according to the variables of age, chronic illness, and duration of treatment did not significantly vary during the study. At the end of pharmaceutical counseling period, more than three fourths of post-surgery patients were considered adherent after hospital discharge. This result indicates a potential opportunity to implement this service in other wards.”
“Objective: To investigate the differences in exposure to medications in a cohort of multi-ethnic pregnant women.